CHATSWORTH, Calif., Feb. 28, 2011 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), reflecting strong instrument sales and continued record sales of consumables and service in its Iris Diagnostics Division (IDD), today announced record revenue of $29.3 million for the fourth quarter ended December 31, 2010, an 11% increase from revenue of $26.5 million in the prior year fourth quarter. Net income for the fourth quarter 2010 was $452,000, or $0.03 per diluted share, compared with net income of $1.9 million, or $0.11 per diluted share, in the prior period. The 2010 results reflect the dilutive impact of IRIS's new Arista Molecular laboratory (Arista). Diluted weighted average shares outstanding for the three months ended December 31, 2010 and 2009, were 17.8 million and 18.0 million, respectively.
